Investor Presentaiton
OPERATING PERFORMANCE DEVELOPMENT
ACROSS PRIVATE LARGE PORTFOLIO COMPANIES (CONT'D)
80
RETAIL (PHARMACY)
REVENUE DEVELOPMENT
+28.1%
+18.3%
EBITDA¹ DEVELOPMENT
KEY DRIVERS
Robust performance of the Retail
(Pharmacy), reflecting overall
improvement in economic activity
and continuing expansion of the
pharmacy chain.
Same-store revenue growth at 14.8%,
up 11.2 ppts y-o-y in 3Q21.
Number of bills issued up 5.9% y-o-y
to 7.4 million in 3Q21.
Average bill size up 18.4% y-o-y to
GEL 18.5 in 3Q21.
GEL MILLION
+31.7%
+21.1%
193
160
147
478
442
566
+34.7%
+24.7%
20
15
16
GEORGIA
CAPITAL
+16.5%
46
50
46
+7.3%
5.4
3Q19
3Q20
3Q21
9M19
9M20
9M21
3Q19
3Q20
3Q21
9M19
9M20
9M21
Added 32 pharmacies over the last 12
months, expanding from 309 to 341
stores
Georgia Capital PLC | 1. Excluding IFRS 16.
38View entire presentation